NEWS RELEASE 

For more information, contact:
Nadine Tosk, 504.483.6957 or nadine@bellsouth.net

FDA CLEARS GENTLEWAVES® -- THE FIRST AND ONLY LIGHT EMITTING DIODE DEVICE FOR THE TREATMENT OF PERIORBITAL WRINKLES AND RHYTIDS

GentleWaves® LED Photomodulation® Proven Effective
for Cosmetic Skin Fitness

Virginia Beach, VA – January 5, 2005.  Light BioScience® announced today that the U.S. Food and Drug Administration (FDA) cleared GentleWaves® Light Emitting Diode (LED) Photomodulation® System for the non-invasive treatment of periorbital (eye area) wrinkles and rhytids. GentleWaves is the first and only LED device to receive marketing approval for a medical claim associated with cosmetic improvement of aging and sun-damaged skin, further validating the science of LED Photomodulation for skin rejuvenation.

“GentleWaves LED Photomodulation is a fundamentally new approach to improving photoaging and environmentally damaged skin that does not rely on high-energy sources and heat damage to photoactivate collagen genes,” said Robert A. Weiss, MD, associate professor of dermatology at Johns Hopkins University School of Medicine in Baltimore, Maryland.  “For the first time, we are both slowing down collagen breakdown and building up new collagen with no pain, no redness and no serious side effects.  GentleWaves’ unique ability to stimulate and/or inhibit cell signaling pathways for skin rejuvenation truly represents the next frontier in anti-aging medicine.”

GentleWaves uses specially coded arrays of light emitting diodes to modulate the activity of living cells.  Unlike other laser, pulsed light or radiofrequency techniques used today for skin rejuvenation, GentleWaves’ exclusive core technology delivers very low-intensity, non-thermal light energy to stimulate collagen and reverse the appearance of photoaging.  With its proprietary and predetermined energy sequencing, the easy-to-use device poses no learning curve or risk of complications. A patient simply sits with his/her face exposed to two panels of over 2,000 yellow cascading LED lights for less than one minute.  The device can also be adjusted to treat the neck and chest areas.  And, for patients seeking a full program of skin fitness, GentleWaves treatment is complemented by a scientifically developed line of cosmeceutical products.

According to lead researcher David H. McDaniel, MD, the FDA clearance of GentleWaves marks the culmination of years of rigorous scientific investigation and successful clinical practice by renowned aesthetic physicians nationwide.  “We are proud that we adhered to the scientific standards the FDA applies to guarantee the efficacy of a new anti-wrinkle device introduced to today’s appearance-conscious consumers,” said the director of the Institute of Anti-Aging Research in Virginia Beach, VA.  

Recognizing the capabilities and benefits of the GentleWaves System, Rick Krupnick, CEO of Light BioScience, enthusiastically announced his excitement regarding the regulatory clearance: “The FDA clearance distinguishes GentleWaves as the first and only LED device to effectively treat periorbital wrinkles. Today’s announcement of medical marketing claims allows us to meet a growing demand from patients who have been waiting for a gentle, pain-free skin fitness regime without side effects, downtime or a huge investment.”   

To assess the safety and efficacy of GentleWaves, the FDA reviewed data from a multi-center clinical study of 54 patients.  After 8 GentleWaves treatments, over 50% of all patients showed measurable improvement in periorbital wrinkle reduction.  Further, of those with more severe wrinkles (category 6-8), 94% exhibited measurable improvement. 

About Light BioScience

Light BioScience, LLC is the leader in the science of LED Photomodulation, a groundbreaking light-based technology for medical and aesthetic applications. Its flagship GentleWaves LED Photomodulation System provides a safe and effective non-invasive and non-ablative solution to photoaging and includes a complete skin care regimen featuring cosmeceuticals that are dermatologist-tested and intended for all skin types. The Company is actively researching other clinical uses of the GentleWaves platform technology, including applications to improve acne, sunburn and wound healing.

Based in Virginia Beach, VA, Light BioScience was established in 2002 and now has over 11 patents issued or pending worldwide.
 
For more information, please visit www.lightbioscience.com.